Dimensional Fund Advisors
ATOS icon

Dimensional Fund Advisors’s Atossa Therapeutics ATOS Stock Holding History

Dimensional Fund Advisors’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-799
Closed -$29K – 3346
2020
Q3 		$29K Buy
+799
New +$38.4K ﹤0.01% 3318

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dimensional Fund Advisors's ATOS Position: Q4 2020 in Review

Dimensional Fund Advisors sold out of Atossa Therapeutics (ATOS) in Q4 2020, closing a stake of 799 shares — an estimated $29K sold.

Dimensional Fund Advisors first reported a position in ATOS in Q3 2020 and held it in 1 quarter. The position peaked at $29K in Q3 2020. 19 funds tracked by Wall St. Rank hold ATOS as of Q4 2020.

  • Dimensional Fund Advisors reported no remaining Atossa Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Dimensional Fund Advisors sold 799 Atossa Therapeutics shares in Q4 2020, an estimated $29K.
  • Dimensional Fund Advisors first reported a position in Atossa Therapeutics in Q3 2020 and held it in 1 quarter.
  • Dimensional Fund Advisors's Atossa Therapeutics position peaked at $29K in Q3 2020.
  • 19 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2020.

Based on Dimensional Fund Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.